(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 166.41 | 152.56 | 161.35 | 9.1% | 3.1% |
Total Expenses | 152.56 | 142.90 | 140.85 | 6.8% | 8.3% |
Profit Before Tax | 13.86 | 9.64 | 20.51 | 43.8% | -32.4% |
Tax | 3.46 | 2.26 | 4.71 | 53.1% | -26.5% |
Profit After Tax | 10.40 | 7.38 | 15.79 | 40.9% | -34.1% |
Earnings Per Share | 2.10 | 1.50 | 3.30 | 40.0% | -36.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Kopran Ltd is a company known for its involvement in the pharmaceutical industry, primarily focusing on the manufacturing and distribution of pharmaceutical products. These products include active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates in a highly competitive market driven by innovation, quality, and regulatory compliance. As of the latest reporting period, Kopran Ltd has not publicly announced any major recent developments or strategic shifts in its business model or product offerings.
In the third quarter of the fiscal year 2025 (Q3FY25), Kopran Ltd reported a total income of ₹166.41 crores. This represents an increase of 9.1% from the previous quarter (Q2FY25), where total income was ₹152.56 crores. Compared to the same quarter in the previous fiscal year (Q3FY24), which recorded a total income of ₹161.35 crores, there is a year-over-year growth of 3.1%. This upward trend in revenue suggests that the company has maintained a positive trajectory in its income generation over the past year.
Kopran Ltd's profitability metrics for Q3FY25 indicate a complex financial performance. The company's profit before tax for the quarter was ₹13.86 crores, marking a significant quarter-over-quarter increase of 43.8% from ₹9.64 crores in Q2FY25. However, this figure represents a year-over-year decrease of 32.4% when compared to the ₹20.51 crores reported in Q3FY24. The tax expense for the quarter was ₹3.46 crores, up 53.1% from the previous quarter's ₹2.26 crores, but down 26.5% from ₹4.71 crores in Q3FY24. Consequently, the profit after tax was ₹10.40 crores, showing a 40.9% increase QoQ from ₹7.38 crores but a 34.1% decline YoY from ₹15.79 crores. Earnings per share for Q3FY25 stood at ₹2.10, which is a 40.0% increase from Q2FY25's ₹1.50, yet a decrease of 36.4% from ₹3.30 in Q3FY24.
The company's total expenses in Q3FY25 amounted to ₹152.56 crores, reflecting a 6.8% increase from the ₹142.90 crores incurred in Q2FY25 and an 8.3% rise compared to the ₹140.85 crores recorded in Q3FY24. This increase in expenses, both QoQ and YoY, is a notable trend that contributes to the overall financial performance of Kopran Ltd. The data highlights a consistent rise in the cost of operations, which may be attributed to various factors such as increased production costs or strategic investments. The financial data presented does not provide specific details on operational efficiencies or ratios such as the P/E ratio, debt-to-equity ratio, or current ratio; therefore, these metrics cannot be calculated from the available information.